BRIGHT MINDS BIOSCIENCES INC. (DRUG)
Data as of , from SEC Form 4 filings.
See up to 3 months of DRUG. The 7-day demo opens the 1M and 3M ranges and puts DRUG on your watchlist.
Start 7-day demoLatest DRUG insider trades
About BRIGHT MINDS BIOSCIENCES INC. (DRUG)
BRIGHT MINDS BIOSCIENCES INC. files with the SEC under CIK 0001827401 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
DRUG Form 4 activity by transaction type, last 90 days
No Form 4 activity for DRUG in the last 90 days.
DRUG insider transactions (Form 4)
122 Form 4 filings on record, the earliest from Oct 17, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 184,331 | $21.70 | $4.00M | |
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 238,097 | $4.53 | $1.08M | |
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 63,173 | $5.92 | $374K | |
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 33,343 | $6.42 | $214K | |
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 8,900 | $7.31 | $65K | |
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 2,600 | $8.80 | $23K | |
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 2,700 | $9.26 | $25K | |
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 19,169 | $11.72 | $225K | |
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 4,609 | $12.35 | $57K | |
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 39,743 | $23.22 | $923K | |
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 7,150 | $24.03 | $172K | |
| Cormorant Asset Management, LP | Open-market purchase | Common Shares | 3,107 | $25.22 | $78K |
DRUG insider trading FAQ
What is the latest insider trade for DRUG?
BRIGHT MINDS BIOSCIENCES INC. (DRUG) has filed no insider reports in the last 90 days. The most recent on record is dated 2024-11-06. The full record for DRUG runs to 2 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying DRUG stock?
No insider purchases of DRUG were filed in the last 90 days. 12 purchases are on record for this company.
How many insiders are selling DRUG stock?
No insider sales of DRUG were filed in the last 90 days.
Where can I see DRUG SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects DRUG Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
2The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Cormorant Asset Management, LP view on EDGAR
- - Cormorant Asset Management, LP view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where DRUG's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow DRUG with a 7-day demo
- DRUG on your watchlist
- Every DRUG Form 4 filing on record
- Up to 3 months of DRUG price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
